HIGHLIGHTS
- who: Xin Lu and collaborators from the Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China have published the research: Treatment of Central Nervous System Infection Caused by Multidrug-Resistant Klebsiella pneumoniae with Colistin Sulfate Intravenously and Intrathecally: A Case Report, in the Journal: Pharmaceuticals 2022, 15, 1482. of 16/04/2018
- what: The antimicrobial regimen based on the intravenous infusion and intrathecal injection of CS combined with tigecycline is effective in the treatment of MDRGNB-caused NCNSIs, wound infections, and lung infections without causing significant adverse effects.
- future: TDM . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.